Iowa has its first confirmed case of H5N1 bird flu in a poultry farm worker, the state's public health department announced.

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.

US pharma giant Pfizer on Friday revealed that the US Food and Drug Administration (FDA) has approved its Braftovi ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with ...

Pfizer Inc. (PFE) said that the U.S. Food and Drug Administration has approved BRAFTOVI (encorafenib) in combination with cetuximab ...

Intelligent Living Application Group Inc. (the "Company" or "Intelligent Living"), a premium lockset manufacturer and distributor headquartered in Hong Kong, today announced its unaudited financial ...

Pfizer said Friday that the Food and Drug Administration approved its treatment for patients with metastatic colorectal cancer.

Pfizer scored an accelerated approval Friday to bring its BRAF inhibitor to first-line colorectal cancer patients.

A Texas man facing execution did not appear at the state Capitol after two failed attempts by lawmakers to issue a subpoena ...

Pfizer (PFE) has received FDA accelerated approval for its drug Braftovi in combination with other therapies for the ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.